Request Deal Involvement
HighLight Capital and Panacea Venture led a $100m Series C funding round in Inmagene Biopharmaceuticals.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
China Renaissance Securities
or
Principals
bidder
HIGHLIGHT CAPITAL
target
INMAGENE BIOPHARMACEUTICALS
bidder
PANACEA VENTURE
bidder
VMS ASSET MANAGEMENT
bidder
TRIWISE CAPITAL
bidder
TMT INVESTMENTS
bidder
SOUTH CHINA VENTURE CAPITAL
bidder
KUNLUN CAPITAL
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite